Options for first line therapy of Hodgkin lymphoma
Hematol Oncol
.
2019 Jun;37 Suppl 1(Suppl Suppl 1):82-86.
doi: 10.1002/hon.2597.
Authors
Jemma Longley
1
,
Peter W M Johnson
1
Affiliation
1
Cancer Research UK Centre, University of Southampton, UK.
PMID:
31187527
PMCID:
PMC6617793
DOI:
10.1002/hon.2597
No abstract available
Publication types
Review
MeSH terms
Hodgkin Disease / diagnosis*
Hodgkin Disease / therapy*
Humans
Prognosis
Grants and funding
9619/CRUK_/Cancer Research UK/United Kingdom